02 Jan 2019

ABSTRACTS DUE MARCH 1 FOR 10TH VENOUS SYMPOSIUM APRIL 11-13

By Larry Storer Venous Symposium International has issued a Call for Abstracts from researchers from around the globe to share their work with peers and industry at the 10th Venous Symposium April 11-13 in New York. Deadline for the online abstract submissions is March 1. After a peer review, accepted

0
02 Jan 2019

SCHAENING ACP KEYNOTE: 2019 LCD DRAFTING,  NOTIFICATION, REVISION TO BE MORE TRANSPARENT

  By Vanessa Salvia Juan Schaening, MD, the executive contractor medical director for Medicare Jurisdiction N, discussed changes to 2019 Local Coverage Determinations during a keynote address at the American College of Phlebology’s 32nd Annual Congress Nov. 9 in Nashville. He said changes are designed to provide transparency in the

0
20 Dec 2018

MCAFEE: CRYPTOMINING AND IoT MALWARE BOTH ROSE OVER 70% IN Q3 2018

    By DeanTakahashi VentureBeat   Cybersecurity firm McAfee said that the cybercriminal underworld is generating 480 new threats per minute. That’s one of the details in the new McAfee Labs Threats Report: December 2018.   McAfee reported that internet of things malware was up 73 percent in the third quarter, while cryptocurrency

0
18 Dec 2018

MERIT MEDICAL ACQUIRES ASSETS OF VASCULAR INSIGHTS DEC 17

  Merit Medical Systems Inc., a manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, announced Dec. 17 that it has acquired substantially all of the assets of Vascular Insights LLC, based in Quincy, Massachusetts. Vascular Insights’ primary assets are the ClariVein IC and ClariVein

0
11 Dec 2018

BOOK REVIEWS: ‘A GUIDE TO TREATING FACE VEINS’

 ‘A Wonderful Resource’   By Joseph D. Raffetto, MD “A Guide to Treating Face Veins” is a wonderful resource and compilation of work by Dr. Ronald Bush and Mrs. Peggy Bush. Facial veins are uncommonly treated in most clinical practices but is a common problem among patients who seek medical

0
11 Dec 2018

VEIN911 CEO FORMS MANAGEMENT SERVICE FOR INDEPENDENT PRACTICES

    The CEO of Vein911 Vein Treatment Centers, 21-year cancer survivor and healthcare industry veteran Chris Pittman, MD, has launched Health Performance Specialists (HPS), a national Management Services Organization for independent physicians. HPS helps independent physicians compete, succeed and thrive in today’s medical practice environment. The organization is designed to disrupt current healthcare

0
21 Nov 2018

ACP CHANGES ITS NAME TO AMERICAN VEIN & LYMPHATIC SOCIETY; AVLS OFFICIAL STATEMENT

By Vanessa Salvia The American College of Phlebology (ACP) has changed its name to the American Vein & Lymphatic Society (AVLS). The organization is still working on its new logo. The American College of Phlebology Foundation will be known as the Foundation for Venous and Lymphatic Disease, or FVLD. During

0
21 Nov 2018

BOSTON SCIENTIFIC ACQUIRING BTG

    Boston Scientific has reached an agreement on the terms of a recommended offer to acquire BTG plc., a United Kingdom-based company that develops and commercializes products used in minimally-invasive procedures, targeting vascular diseases and cancer, as well as acute care pharmaceuticals. Under the terms of the transaction, holders

0
13 Nov 2018

VIETHsymposium: INTACT VASCULAR EVENTS

Intact Vascular Inc., a private medical device company committed to developing solutions for minimally invasive peripheral vascular procedures, has announced the schedule of key presentations to be featured during a lunch symposium co-sponsored with Philips at the 45th annual VEITHsymposium in New York City on Thursday, Nov.15. Following the symposium, an

0
12 Nov 2018

26,000-PERSON STUDY: FISH OIL AND VITAMIN D PILLS NO GUARD AGAINST CANCER OR SERIOUS HEART TROUBLE

By Liz Szabo Kaiser Health News A widely anticipated study has concluded that neither vitamin D nor fish oil supplements prevent cancer or serious heart-related problems in healthy older people, according to research presented Nov. 10 at the American Heart Association Scientific Sessions. Researchers defined serious heart problems as the

0